3-硝基吡唑并[1,5-a]嘧啶-5(4H)-酮
|
N587887-250mg
|
≥98% |
1919868-75-9 |
250mg
|
¥ 82.9
|
期货,请咨询 |
阿拉丁 |
PMPBO
|
N587877-250mg
|
≥98% |
1909333-82-9 |
250mg
|
¥ 199.9
|
现货 |
阿拉丁 |
PMPBO
|
N587877-1g
|
≥98% |
1909333-82-9 |
1g
|
¥ 599.9
|
现货 |
阿拉丁 |
(2-硝基苯基)甲胺
|
N587872-1g
|
≥98% |
1904-78-5 |
1g
|
¥ 1393.9
|
期货,请咨询 |
阿拉丁 |
N-甲基哌啶-4-甲酰胺盐酸盐
|
N587869-250mg
|
≥95% |
1903-75-9 |
250mg
|
¥ 106.9
|
现货 |
阿拉丁 |
N1,N2-双(5-甲基-[1,1'-联苯]-2-基)草酰胺
|
N587752-5g
|
≥98% |
1809289-04-0 |
5g
|
¥ 3178.9
|
现货 |
阿拉丁 |
N1,N2-双(5-甲基-[1,1'-联苯]-2-基)草酰胺
|
N587752-250mg
|
≥98% |
1809289-04-0 |
250mg
|
¥ 289.9
|
现货 |
阿拉丁 |
N1,N2-双(5-甲基-[1,1'-联苯]-2-基)草酰胺
|
N587752-1g
|
≥98% |
1809289-04-0 |
1g
|
¥ 633.9
|
期货,请咨询 |
阿拉丁 |
N1,N2-双(4-羟基-2,6-二甲基苯基)草酰胺
|
N587751-5g
|
≥97% |
1809288-95-6 |
5g
|
¥ 299.9
|
现货 |
阿拉丁 |
N1,N2-双(4-羟基-2,6-二甲基苯基)草酰胺
|
N587751-25g
|
≥97% |
1809288-95-6 |
25g
|
¥ 1249.9
|
现货 |
阿拉丁 |
N1,N2-双(4-羟基-2,6-二甲基苯基)草酰胺
|
N587751-250mg
|
≥97% |
1809288-95-6 |
250mg
|
¥ 39.9
|
现货 |
阿拉丁 |
N1,N2-双(4-羟基-2,6-二甲基苯基)草酰胺
|
N587751-1g
|
≥97% |
1809288-95-6 |
1g
|
¥ 79.9
|
现货 |
阿拉丁 |
9-(4-硝基苯基)咔唑
|
N587620-5g
|
≥98% |
16982-76-6 |
5g
|
¥ 669.9
|
现货 |
阿拉丁 |
9-(4-硝基苯基)咔唑
|
N587620-250mg
|
≥98% |
16982-76-6 |
250mg
|
¥ 69.9
|
现货 |
阿拉丁 |
8-羟基-6-硝基喹啉
|
N587598-1g
|
≥95% |
16727-28-9 |
1g
|
¥ 634.9
|
期货,请咨询 |
阿拉丁 |
N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-d]嘧啶-4-胺二盐酸盐
|
N587569-1g
|
≥97% |
1655430-59-3 |
1g
|
¥ 216.9
|
期货,请咨询 |
阿拉丁 |
N-乙基-N-异丙基亚硝基胺
|
N587539-5g
|
≥98% |
16339-04-1 |
5g
|
¥ 1583.9
|
期货,请咨询 |
阿拉丁 |
N-乙基-N-异丙基亚硝基胺
|
N587539-250mg
|
≥98% |
16339-04-1 |
250mg
|
¥ 314.9
|
现货 |
阿拉丁 |
N-乙基-N-异丙基亚硝基胺
|
N587539-1g
|
≥98% |
16339-04-1 |
1g
|
¥ 442.9
|
现货 |
阿拉丁 |
N-乙基-N-异丙基亚硝基胺
|
N587539-100mg
|
≥98% |
16339-04-1 |
100mg
|
¥ 195.9
|
现货 |
阿拉丁 |
5-(3-硝基苯基)-1H-吡唑-3-羧酸
|
N587414-1g
|
≥95% |
1557038-82-0 |
1g
|
¥ 866.9
|
现货 |
阿拉丁 |
3-硝基喹啉-2,4-二醇
|
N587365-1g
|
≥98% |
15151-57-2 |
1g
|
¥ 49.9
|
现货 |
阿拉丁 |
5-硝基-1H-1,2,3-三唑
|
N587285-5g
|
≥98% |
14544-45-7 |
5g
|
¥ 639.9
|
现货 |
阿拉丁 |
5-硝基-1H-1,2,3-三唑
|
N587285-250mg
|
≥98% |
14544-45-7 |
250mg
|
¥ 94.9
|
现货 |
阿拉丁 |